跳至主要内容
临床试验/NL-OMON28028
NL-OMON28028招募中不适用

Clinical Trial to Evaluate Safety and Dose Response Using the C2 CryoBalloon 180 Ablation System for the Treatment of Dysplastic Barrett's Esophagus

C2 Therapeutics, Inc.0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with flat- type BE esophagus, with an indication for ablation therapy, defined as:
  • - Diagnosis of LGD or HGD in BE (confirmed by central pathology review), OR

排除标准

  • 1. Esophageal stenosis preventing advancement of a therapeutic endoscope.
  • 2. Any endoscopically visualized lesion such as ulcers, masses or nodules. Neoplastic nodules must first be treated with ER >6 weeks prior to planned treatment under this protocol.

研究者

相似试验